PRIMR Announces Competitive Grant Program for Academic Clinical Trials

By: David Grew MD MPH

"We're here to make a change – that's why we're excited to announce our new Academic Clinical Trial Grant Program (PRIMR A.C.T. Grant Program)!"

∗ ∗ ∗

At PRIMR, we've had the privilege of collaborating with dedicated Principal Investigators (PIs) from various academic institutions and cooperative groups. Through these partnerships, we've come to realize a common challenge - the lack of funding for essential patient education content and trial awareness support.

We're here to make a change – that's why we're excited to announce our new Academic Clinical Trial Grant Program (PRIMR A.C.T. Grant Program)!

‍

What's Included in the Grant?

Video Services: Tailored video content for your trial.

IRB Submission Support: Streamlined assistance for speedy approval.

PRIMR Website Feature: Showcase your trial on our platform for increased visibility.

Blog Post Promotion: A dedicated blog post to boost trial awareness.

Point of Care Distribution: Deliver trial information directly to participants via a QR-coded one-pager PDF.

Social Promotion: Regular featured posts across PRIMR social channels

Participant Referrals: Gain organic inbound eligible participants through PRIMR's website.

‍

The PRIMR Competitive Grant Program

PRIMR is on a mission to support highly qualified cancer trials by providing a competitive grant that includes a range of valuable services. To qualify, trials must be related to cancer, with no requirement for radiation involvement. Priority will be given to trials with minimal or no industry support.

The application deadline is on December 1, 2023. The grant will be awarded before the year ends on December 31, 2023.

—

Join Us in Empowering Academic Trials

To apply for PRIMR’s ACT Grant Program, click here to submit your application.

—

Stay tuned for more updates and opportunities to make a meaningful impact in the world of clinical trials.

Other Posts

This image represents the thumbnail for the blog entitled The Untapped Potential of a Century-Old Treatment: Reviving Low-Dose Radiation Therapy for Osteoarthritis

The Untapped Potential of a Century-Old Treatment: Reviving Low-Dose Radiation Therapy for Osteoarthritis

This blog tackles the underutilized option of low-dose radiation for treating osteoarthritis in the US, a method widely ignored due to entrenched medical norms and pervasive radiophobia, despite its potential benefits and minimal side effects. It explores the history, efficacy, and misconceptions surrounding this treatment, advocating for its consideration among suitable patients who do not respond well to conventional therapies.

The thumbnail above represents the blog entitled Navigating the Evolving Landscape of Informed Consent in Clinical Trials: Draft FDA Guidance and the PRIMR Approach

Navigating the Evolving Landscape of Informed Consent in Clinical Trials: Draft FDA Guidance and the PRIMR Approach

The blog explores the transformative potential of the recent FDA guidance on informed consent processes. It highlights how PRIMR's innovative approach to patient education exemplifies the FDA's vision for a more accessible and engaging informed consent experience in clinical trials.

This image thumbnail represents the strategic partnership between UroToday and PRIMR for the blog announcement.

UroToday and PRIMR Announce Strategic Partnership to Enhance Clinical Trial Awareness

UroToday & PRIMR partner to boost clinical trial awareness in genitourinary oncology, merging UroToday's global network with PRIMR's educational content. Aimed at increasing patient enrollment, this collaboration will make trial information accessible, bridging gaps between patients & trials.